BIOINF OÜ

Active Registry code 11359595 OÜ Tallinn Registered 8 Mar 2007
Compare

BIOINF OÜ is a OÜ based in Tallinn, registry code 11359595, status: active. Main activity: Research and experimental development on biotechnology. Its annual report for 2023 shows revenue of €0 and 0 employees.

Turnover
—
State taxes
50 €
↑ 4 900.0% vs Q4 2024
Labour taxes
0 €
Employees
—

Q1 2025 · data from the Tax and Customs Board (EMTA)

Position in the industry Scientific research and development · EMTAK 72

  • Revenue · 2023 0 €
    industry median 76 € · companies in the industry: 1 030

Taxes and turnover

Q2 2022 – Q1 2025
Turnover, € Q1 2024: 0 € · industry median 14 938 € · above 2% of the industry
05 00010 00015 00020 000Q2 2022 Company: 0 € Industry median: 19 195 €Q2·22Q3 2022 Company: 0 € Industry median: 15 454 €Q4 2022 Company: 0 € Industry median: 16 080 €Q4·22Q1 2023 Company: 0 € Industry median: 17 387 €Q2 2023 Company: 0 € Industry median: 15 775 €Q2·23Q3 2023 Company: 0 € Industry median: 13 094 €Q4 2023 Company: 0 € Industry median: 15 375 €Q4·23Q1 2024 Company: 0 € Industry median: 14 938 €Q2 2024 Company: — Industry median: 14 999 €Q2·24Q3 2024 Company: — Industry median: 11 985 €Q4 2024 Company: — Industry median: 16 752 €Q4·24Q1 2025 Company: — Industry median: 15 203 €Q1·2505 00010 00015 00020 000Q2 2023 Company: 0 € Industry median: 15 775 €Q3 2023 Company: 0 € Industry median: 13 094 €Q3·23Q4 2023 Company: 0 € Industry median: 15 375 €Q1 2024 Company: 0 € Industry median: 14 938 €Q1·24Q2 2024 Company: — Industry median: 14 999 €Q3 2024 Company: — Industry median: 11 985 €Q3·24Q4 2024 Company: — Industry median: 16 752 €Q1 2025 Company: — Industry median: 15 203 €Q1·25
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

State taxes, € Q1 2025: 50 € · +4 900.0% vs Q4 2024
0200400600800Q2 2022 Company: 510 €Q2·22Q3 2022 Company: 510 €Q4 2022 Company: 510 €Q4·22Q1 2023 Company: 510 €Q2 2023 Company: 340 €Q2·23Q3 2023 Company: 680 €Q4 2023 Company: 383 €Q4·23Q1 2024 Company: 355 €Q2 2024 Company: 50 €Q2·24Q3 2024 Company: 100 €Q4 2024 Company: 1 €Q4·24Q1 2025 Company: 50 €Q1·250200400600800Q2 2023 Company: 340 €Q3 2023 Company: 680 €Q3·23Q4 2023 Company: 383 €Q1 2024 Company: 355 €Q1·24Q2 2024 Company: 50 €Q3 2024 Company: 100 €Q3·24Q4 2024 Company: 1 €Q1 2025 Company: 50 €Q1·25
Figures by quarter
Quarter Turnover, € State taxes, € Labour taxes, € Employees
Q1 2025 — 50 — —
Q4 2024 — 1 — —
Q3 2024 — 100 — —
Q2 2024 — 50 — —
Q1 2024 — 355 212 —
Q4 2023 — 383 212 —
Q3 2023 — 680 424 —
Q2 2023 — 340 212 —
Q1 2023 — 510 318 —
Q4 2022 — 510 318 —
Q3 2022 — 510 318 —
Q2 2022 — 510 318 —
Q1 2022 4 200 1 224 318 —

Financials by year

2015 – 2024
Revenue, € thousand 2023: 0 € · −100.0% vs 2022 · industry median 76 € · above 5% of the industry
0501001502002015 Company: — Industry median: —20152016 Company: — Industry median: —20162017 Company: — Industry median: —20172018 Company: — Industry median: —20182019 Company: 178 491 € Industry median: 0 €20192020 Company: 14 355 € Industry median: 150 €20202021 Company: 11 000 € Industry median: 0 €20212022 Company: 3 200 € Industry median: 103 €20222023 Company: 0 € Industry median: 76 €20232024 Company: — Industry median: 0 €20240501001502002017 Company: — Industry median: —2018 Company: — Industry median: —20182019 Company: 178 491 € Industry median: 0 €2020 Company: 14 355 € Industry median: 150 €20202021 Company: 11 000 € Industry median: 0 €2022 Company: 3 200 € Industry median: 103 €20222023 Company: 0 € Industry median: 76 €2024 Company: — Industry median: 0 €2024
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € thousand 2024: -134 958 € · −1 567.4% vs 2023 · industry median 0 € · above 2% of the industry
-150-100-500501002015 Company: — Industry median: —20152016 Company: — Industry median: —20162017 Company: — Industry median: —20172018 Company: — Industry median: —20182019 Company: 64 382 € Industry median: 3 €20192020 Company: -83 416 € Industry median: 28 €20202021 Company: -22 719 € Industry median: 1 €20212022 Company: -7 716 € Industry median: 0 €20222023 Company: -8 094 € Industry median: 0 €20232024 Company: -134 958 € Industry median: 0 €2024-150-100-500501002017 Company: — Industry median: —2018 Company: — Industry median: —20182019 Company: 64 382 € Industry median: 3 €2020 Company: -83 416 € Industry median: 28 €20202021 Company: -22 719 € Industry median: 1 €2022 Company: -7 716 € Industry median: 0 €20222023 Company: -8 094 € Industry median: 0 €2024 Company: -134 958 € Industry median: 0 €2024
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit margin, % 2022: -241.1 % · −34.6 pp vs the year before · industry median 17.7 % · above 2% of the industry
-600-400-20002002015 Company: — Industry median: —20152016 Company: — Industry median: —20162017 Company: — Industry median: —20172018 Company: — Industry median: —20182019 Company: 36.1 % Industry median: 12.7 %20192020 Company: -581.1 % Industry median: 23.8 %20202021 Company: -206.5 % Industry median: 25.1 %20212022 Company: -241.1 % Industry median: 17.7 %20222023 Company: — Industry median: 16.8 %20232024 Company: — Industry median: 15.8 %2024-600-400-20002002017 Company: — Industry median: —2018 Company: — Industry median: —20182019 Company: 36.1 % Industry median: 12.7 %2020 Company: -581.1 % Industry median: 23.8 %20202021 Company: -206.5 % Industry median: 25.1 %2022 Company: -241.1 % Industry median: 17.7 %20222023 Company: — Industry median: 16.8 %2024 Company: — Industry median: 15.8 %2024
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € thousand 2024: 97 686 € · −57.9% vs 2023
01002003004002015 Company: —20152016 Company: —20162017 Company: —20172018 Company: —20182019 Company: 321 660 €20192020 Company: 238 713 €20202021 Company: 232 223 €20212022 Company: 231 631 €20222023 Company: 232 249 €20232024 Company: 97 686 €202401002003004002017 Company: —2018 Company: —20182019 Company: 321 660 €2020 Company: 238 713 €20202021 Company: 232 223 €2022 Company: 231 631 €20222023 Company: 232 249 €2024 Company: 97 686 €2024
Equity, € thousand 2024: 42 105 € · −76.2% vs 2023
01002003002015 Company: —20152016 Company: —20162017 Company: —20172018 Company: —20182019 Company: 299 007 €20192020 Company: 215 591 €20202021 Company: 192 873 €20212022 Company: 185 157 €20222023 Company: 177 063 €20232024 Company: 42 105 €202401002003002017 Company: —2018 Company: —20182019 Company: 299 007 €2020 Company: 215 591 €20202021 Company: 192 873 €2022 Company: 185 157 €20222023 Company: 177 063 €2024 Company: 42 105 €2024
Employees 2024: 0 · industry median 1 · above 2% of the industry
0.00.51.01.52.02015 Company: 2 Industry median: —20152016 Company: 2 Industry median: —20162017 Company: 2 Industry median: —20172018 Company: 2 Industry median: 120182019 Company: 2 Industry median: 120192020 Company: 2 Industry median: 120202021 Company: 2 Industry median: 120212022 Company: 0 Industry median: 220222023 Company: 0 Industry median: 120232024 Company: 0 Industry median: 120240.00.51.01.52.02017 Company: 2 Industry median: —2018 Company: 2 Industry median: 120182019 Company: 2 Industry median: 12020 Company: 2 Industry median: 120202021 Company: 2 Industry median: 12022 Company: 0 Industry median: 220222023 Company: 0 Industry median: 12024 Company: 0 Industry median: 12024
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2024 — -134 958 0 97 686 42 105 0
2023 0 -8 094 0 232 249 177 063 0
2022 3 200 -7 716 0 231 631 185 157 0
2021 11 000 -22 719 29 415 232 223 192 873 2
2020 14 355 -83 416 56 062 238 713 215 591 2
2019 178 491 64 382 43 351 321 660 299 007 2
2018 — — — — — 2
2017 — — — — — 2
2016 — — — — — 2
2015 — — — — — 2
2014 — — — — — 2
2013 — — — — — 2
2012 — — — — — 2
2011 — — — — — 0
2010 — — — — — 0
2009 — — — — — 0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2024

Return on equity (ROE)
-320.5 %
Net profit / equity
Return on assets (ROA)
-138.2 %
Net profit / assets
Equity ratio
43.1 %
Equity / assets
Debt ratio
56.9 %
Liabilities / assets
Current ratio
2.79
Current assets / current liabilities

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2024 1 Jan 2024 – 31 Dec 2024 3 Jul 2025 Company’s own e-Äriregister
2023 1 Jan 2023 – 31 Dec 2023 9 Dec 2024 Company’s own e-Äriregister
2022 1 Jan 2022 – 31 Dec 2022 5 Dec 2024 Company’s own e-Äriregister
2021 1 Jan 2021 – 31 Dec 2021 9 Sep 2022 Company’s own e-Äriregister
2020 1 Jan 2020 – 31 Dec 2020 28 Jun 2021 Company’s own e-Äriregister
2019 1 Jan 2019 – 31 Dec 2019 27 Oct 2020 Company’s own e-Äriregister

Board

  • Toomas Neuman
    Board member · since 8 Mar 2007
  • Nasdaq CSD SE
    Keeper of the share register · since 27 Sep 2017

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Owner in

Beneficial owners

Founders and other persons

shared board members, owners or beneficial owners

Activities (EMTAK)

  • 72111Research and experimental development on biotechnology Main
Rulings
Number, date Title Deadline State Document
Ä 10107056 / 9
8 Oct 2026
Amendment entry In force
8 Oct 2026
PDF
Ä 10107056 / M6
18 Sep 2026
Warning of a fine: annual report not filed 2 Nov 2026 In force
3 Oct 2026
PDF
Ä 10107056 / M5
4 Nov 2024
Fine for not filing the report 5 Dec 2024 In force
6 Dec 2024
PDF
Ä 10107056 / M4
12 Sep 2024
Warning of a fine: annual report not filed 28 Nov 2024 In force
29 Oct 2024
PDF
Ä 10107056 / M3
2 May 2024
Repeated fine for not filing the report 2 Jun 2024 In force
3 Jun 2024
PDF
Ä 10107056 / M2
24 Jan 2024
Fine for not filing the report 24 Feb 2024 In force
25 Feb 2024
PDF
Ä 10107056 / M1
26 Sep 2023
Warning of a fine: annual report not filed 26 Oct 2023 In force
26 Sep 2023
PDF
Ä 10107056 / 8
17 Jan 2018
Amendment entry In force
17 Jan 2018
PDF
Ä 10107056 / 7
30 Nov 2017
Amendment entry In force
30 Nov 2017
PDF
Ä 10107056 / 6
27 Sep 2017
Amendment entry In force
27 Sep 2017
PDF
Ä 10107056 / 5
14 Sep 2016
Amendment entry In force
14 Sep 2016
PDF
Ä 10107056 / 4
2 Feb 2012
Amendment entry In force
2 Feb 2012
PDF
Ä 10107056 / 3
28 Dec 2011
Entry refused: deficiencies not eliminated In force
29 Dec 2011
PDF
Ä 107056 / 2
17 Feb 2009
Note on registration of shares in the Estonian central register of securities In force
17 Feb 2009
PDF
Ä 107056
8 Mar 2007
First entry In force
8 Mar 2007
PDF

Sources: e-Äriregister and EMTA. Data updated 31 Oct 2026. Open at the source ↗ · Report an error in the data